Maternal arsenic exposure, arsenic methylation efficiency, and birth outcomes in the biomarkers of exposure to ARsenic (BEAR) pregnancy cohort in Mexico

Environmental Health Perspectives

Volumn 123, Issue 2, 2015, Pages 186-192

  Laine, Jessica E ^a   Bailey, Kathryn A ^b   Rubio Andrade, Marisela ^c   Olshan, Andrew F ^a,d   Smeester, Lisa ^b   Drobná, Zuzana ^a   Herring, Amy H ^a,d   Stýblo, Miroslav ^a,b   García Vargas, Gonzalo G ^c   Fry, Rebecca C ^b  

^a IL   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^d UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; DRINKING WATER; TRACE ELEMENT; BIOLOGICAL MARKER; POLLUTANT;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BIOLOGICAL MONITORING; BIRTH WEIGHT; FEMALE; FETUS; FLUID INTAKE; GESTATIONAL AGE; HUMAN; LIMIT OF DETECTION; MALE; METHYLATION; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; URINALYSIS; WATER QUALITY; WATER SAMPLING; YOUNG ADULT; BODY SIZE; CHEMISTRY; ENVIRONMENTAL EXPOSURE; METABOLISM; MEXICO; NEWBORN; POLLUTANT; STATISTICS AND NUMERICAL DATA; TOXICITY; URINE;

ADULT; ARSENIC; BIOMARKERS; BODY SIZE; DRINKING WATER; ENVIRONMENTAL POLLUTANTS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; MATERNAL EXPOSURE; MEXICO; PREGNANCY; PROSPECTIVE STUDIES;

EID: 84923024244     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1307476.     Document Type: Article

References (50)

1. Boyle A, Reddy UM. 2012. Epidemiology of cesarean delivery: the scope of the problem. Semin Perinatol 36:308–314.
2. Buchet JP, Lauwerys R, Roels H. 1981. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, mono-methylarsonate, or dimethylarsinate in man. Int Arch Occup Environ Health 48:71–79.
3. Bundschuh J, Litter MI, Parvez F, Román-Ross G, Nicolli HB, Jean JS, et al. 2012. One century of arsenic exposure in Latin America: a review of history and occurrence from 14 countries. Sci Total Environ 429:2–35.
4. Caldwell KL, Jones RL, Verdon CP, Jarrett JM, Caudill SP, Osterloh JD. 2009. Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003–2004. J Expo Sci Environ Epidemiol 19:59–68.
5. Centeno JA, Tseng CH, Van der Voet GB, Finkelman RB. 2007. Global impacts of geogenic arsenic: a medical geology research case. Ambio 36:78–81.
6. Chen CJ, Chiou HY, eds. 2011. Health Hazards of Environmental Arsenic Poisoning: From Epidemic to Pandemic. Hackensack, NJ:World Scientific.
7. Choi BS, Choi SJ, Kim DW, Huang M, Kim NY, Park KS, et al. 2010. Effects of repeated seafood consumption on urinary excretion of arsenic species by volun-teers. Arch Environ Contam Toxicol 58:222–229.
8. Concha G, Vogler G, Lezcano D, Nermell B, Vahter M. 1998. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 44:185–190.
9. Del Razo LM, García-Vargas GG, Valenzuela OL, Castellanos EH, Sánchez-Peña LC, Currier JM, et al. 2011. Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapán and Lagunera regions in Mexico. Environ Health 10:73; doi:10.1186/1476-069X-10-73.
10. Del Razo LM, García-Vargas GG, Vargas H, Albores A, Gonsebatt ME, Montero R, et al. 1997. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch Toxicol 71:211–217.
11. Devesa V, Maria Del Razo L, Adair B, Drobna Z, Waters SB, Hughes MF, et al. 2004. Compre-hensive analysis of arsenic metabolites by pH-specific hydride generation atomic absorption spectrometry. J Anal At Spectrom 19:1460–1467.
12. Gardner RM, Engström K, Bottai M, Hoque WA, Raqib R, Broberg K, et al. 2012. Pregnancy and the methyltransferase genotype independently influence the arsenic methylation phenotype. Pharmacogenet Genomics 22:508–516.
13. Gardner RM, Nermell B, Kippler M, Grandér M, Li L, Ekström EC, et al. 2011. Arsenic methylation efficiency increases during the first trimester of pregnancy independent of folate status. Reprod Toxicol 31:210–218.
14. Gebel T. 2000. Confounding variables in the envi-ronmental toxicology of arsenic. Toxicology 144:155–162.
15. Hernandez-Zavala A, Drobna Z, Styblo M, Thomas DJ. 2009. Analysis of arsenical metabolites in biolog-ical samples. Curr Protoc Toxicol 42:4.33.1–4.33.17
16. Hernández-Zavala A, Matoušek T, Drobná Z, Paul DS, Walton F, Adair BM, et al. 2008. Speciation analysis of arsenic in biological matrices by auto-mated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer). J Anal At Spectrom 23:342–351.
17. Hopenhayn C, Ferreccio C, Browning SR, Huang B, Peralta C, Gibb H, et al. 2003a. Arsenic exposure from drinking water and birth weight. Epidemiology 14:593–602.
18. Hopenhayn C, Huang B, Christian J, Peralta C, Ferreccio C, Atallah R, et al. 2003b. Profile of urinary arsenic metabolites during pregnancy. Environ Health Perspect 111:1888–1891.
19. International Agency for Research on Cancer. 2004. Some Drinking-Water Disinfectants and Contaminants, including Arsenic. IARC Monogr Eval Carcinog Risk Hum 84. Available: http://monographs.iarc.fr/ENG/Monographs/vol84/mono84.pdf [accessed 10 October 2014]
20. Kapaj S, Peterson H, Liber K, Bhattacharya P. 2006. Human health effects from chronic arsenic poisoning—a review. J Environ Sci Health A Tox Hazard Subst Environ Eng 41:2399–2428.
21. Kwok RK, Kaufmann RB, Jakariya M. 2006. Arsenic in drinking-water and reproductive health outcomes: a study of participants in the Bangladesh Integrated Nutrition Programme. J Health Popul Nutr 24:190–205.
22. Le XC, Ma M. 1998. Short-column liquid chromatog-raphy with hydride generation atomic fluores-cence detection for the speciation of arsenic. Anal Chem 70:1926–1933.
23. Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J, et al. 2012. Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect 120:1658–1670; doi:10.1289/ehp.1104579.
24. Montes-Núñez S, Chávez-Corral DV, Reza-López S, Sanin LH, Acosta-Maldonado B, Levario-Carrillo M. 2011. Birth weight in children with birth defects. Birth Defects Res A Clin Mol Teratol. 91:102–107.
25. Montgomery KS. 2000. Apgar scores: examining the long-term significance. J Perinat Educ 9:5–9.
26. Myers SL, Lobdell DT, Liu Z, Xia Y, Ren H, Li Y, et al. 2010. Maternal drinking water arsenic exposure and perinatal outcomes in Inner Mongolia, China. J Epidemiol Community Health 64:325–329.
27. Navas-Acien A, Francesconi KA, Silbergeld EK, Guallar E. 2011. Seafood intake and urine concen-trations of total arsenic, dimethylarsinate and arsenobetaine in the US population. Environ Res 111:110–118.
28. Nermell B, Lindberg AL, Rahman M, Berglund M, Persson LA, El Arifeen S, et al. 2008. Urinary arsenic concentration adjustment factors and malnutrition. Environ Res 106:212–218.
29. Nordstrom DK. 2002. Public health. Worldwide occurrences of arsenic in ground water. Science 296:2143–2145.
30. Rahman A, Vahter M, Smith AH, Nermell B, Yunus M, El Arifeen S, et al. 2009. Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh. Am J Epidemiol 169:304–312.
31. Rahman M, Ng JC, Naidu R. 2009. Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ Geochem Health 31(suppl 1):189–200.
32. Rios JM, Tufiño-Olivares E, Reza-López S, Sanin LH, Levario-Carrillo M. 2008. Birthweight percentiles by gestational age and gender for children in the north of Mexico. Paediatr Perinat Epidemiol 22:188–194.
33. Secretaría de Salud–Estados Unidos Mexicanos. 2000. Modificación a la norma oficial Mexicana nom-127-ssa1-1994, salud ambiental. Agua para uso y consumo humano. Límites permisibles de calidad y tratamientos a que debe someterse el agua para su potabilización. Available: http://www.salud.gob.mx/unidades/cdi/nom/m127ssa14.html [accessed 10 October 2014].
34. Slotnick MJ, Meliker JR, Nriagu JO. 2006. Effects of time and point-of-use devices on arsenic levels in Southeastern Michigan drinking water, USA. Sci Total Environ 369:42–50.
35. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, von Ehrenstein O, et al. 2006. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect 114:1293–1296; doi:10.1289/ehp.8832.
36. Steinmaus CM, Yuan Y, Smith AH. 2005. The temporal stability of arsenic concentrations in well water in western Nevada. Environ Res 99:164–168.
37. Thomas DJ, Styblo M, Lin S. 2001. The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol 176:127–144.
38. Tseng CH. 2007a. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 25:1–22.
39. Tseng CH. 2007b. Metabolism of inorganic arsenic and non-cancerous health hazards associated with chronic exposure in humans. J Environ Biol 28(2 suppl):349–357.
40. Uddin R, Huda NH. 2011. Arsenic poisoning in Bangladesh. Oman Med J 26:207; doi:10.5001/omj.2011.51.
41. Vahter M. 1999. Methylation of inorganic arsenic in different mammalian species and population groups. Sci Prog 82 (Pt 1):69–88.
42. Vahter M. 2002. Mechanisms of arsenic biotransformation. Toxicology 181–182:211–217.
43. Vahter M. 2009. Effects of arsenic on maternal and fetal health. Annu Rev Nutr 29:381–399.
44. Vahter M, Concha G. 2001. Role of metabolism in arsenic toxicity. Pharmacol Toxicol 89:1–5.
45. Vahter ME, Li L, Nermell B, Rahman A, El Arifeen S, Rahman M, et al. 2006. Arsenic exposure in pregnancy: a population-based study in Matlab, Bangladesh. J Health Popul Nutr 24:236–245.
46. Valenzuela OL, Borja-Aburto VH, Garcia-Vargas GG, Cruz-Gonzalez MB, Garcia-Montalvo EA, Calderon-Aranda ES, et al. 2005. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ Health Perspect 113:250–254; doi:10.1289/ehp.7519.
47. WHO (World Health Organization). 1993. Guidelines for Drinking Water Quality. 2nd ed. Geneva:WHO. Available: http://www.who.int/water_sanitation_health/dwq/gdwq2v1/en/[accessed 14 January 2015].
48. Wilcox AJ, Weinberg CR, Basso O. 2011. On the pitfalls of adjusting for gestational age at birth. Am J Epidemiol 174:1062–1068.
49. Yang CY, Chang CC, Tsai SS, Chuang HY, Ho CK, Wu TN. 2003. Arsenic in drinking water and adverse pregnancy outcome in an arseniasisendemic area in northeastern Taiwan. Environ Res 91:29–34.
50. Yassine H, Kimzey MJ, Galligan MA, Gandolfi AJ, Stump CS, Lau SS. 2012. Adjusting for urinary creatinine overestimates arsenic concentrations in diabetics. Cardiorenal Med 2:26–32.